P07900 |
HS90A_HUMAN |
Acute upper respiratory infection [ICD-11: CA07] |
P07900 |
HS90A_HUMAN |
Asthma [ICD-11: CA23] |
P07900 |
HS90A_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P07900 |
HS90A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P07900 |
HS90A_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P07900 |
HS90A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P07900 |
HS90A_HUMAN |
Lung cancer [ICD-11: 2C25] |
P07900 |
HS90A_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P07900 |
HS90A_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P07900 |
HS90A_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P07900 |
HS90A_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P07900 |
HS90A_HUMAN |
Encephalopathy [ICD-11: 8E47] |
P07900 |
HS90A_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
P07900 |
HS90A_HUMAN |
Melanoma [ICD-11: 2C30] |
P07900 |
HS90A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P07900 |
HS90A_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P07900 |
HS90A_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P07900 |
HS90A_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P07900 |
HS90A_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |